[Antimicrobial resistance and clinical significant resistance mechanisms of Salmonella isolated in 2014-2018 in St.Petersburg, Russia.]

Autor:	Egorova SA; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Kaftyreva LA; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia.; State Educational Institution of the Higher Professional Education «North-Western state medical University n.a. I.I. Mechnikov» of the Ministry of Health of the Russian Federation, 191015, Saint-Petersburg, Russia., Suzhaeva LV; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Zabrovskaia AV; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Voitenkova EV; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Matveeva ZN; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Ostankova YV; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Likhachev IV; Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia., Satosova NV; State Educational Institution of the Higher Professional Education «North-Western state medical University n.a. I.I. Mechnikov» of the Ministry of Health of the Russian Federation, 191015, Saint-Petersburg, Russia., Kitsbabashvili RV; ANO «Medical Center XXI Century», 194044, Saint-Petersburg, Russia., Smirnova EV; FBUZ «Center for Hygiene and Epidemiology in St. Petersburg», division № 3, 192012, Saint-Petersburg, Russia., Semchenkova LI; FBUZ «Center for Hygiene and Epidemiology in St. Petersburg», division № 3, 192012, Saint-Petersburg, Russia., Bystraya TE; FBUZ «Center for Hygiene and Epidemiology in St. Petersburg», division № 3, 192012, Saint-Petersburg, Russia., Sokol'nik SE; FBUZ «Center for Hygiene and Epidemiology in St. Petersburg», division № 6, 198329, Saint-Petersburg, Russia., Utkina NP; FBUZ «Center for Hygiene and Epidemiology in St. Petersburg», division № 6, 198329, Saint-Petersburg, Russia., Sikhando LY; FBUZ «Center for Hygiene and Epidemiology in St. Petersburg», division № 6, 198329, Saint-Petersburg, Russia.
Jazyk:	ruština
Zdroj:	Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2019; Vol. 64 (10), pp. 620-626.
DOI:	10.18821/0869-2084-2019-64-10-620-626
Abstrakt:	The article presents the results of antimicrobial resistance monitoring of Salmonella isolated from children and adults with diarrhea in St. Petersburg in 2014-2018. In 746 isolates of 42 serovars more than 90,0% belonged to three: S. enteritidis (79,6%), S. typhimurium (6,8%) and S. infantis (3,8%). The antimicrobial susceptibility testing (according the EUCAST) to 7 classes of antimicrobials revealed the resistance in 78,6% of Salmonella. Low-level quinolone resistance (MIC of ciprofloxacin 0,12-0,5 mg/l) was detected in 63,3% isolates (S. enteritidis -71,0%, S. typhimurium - 15,7%, S. infantis - 89,3%) and was due to five kinds of single nucleotide substitutions in gyrA: Asp87Tyr - 36,1% of studied isolates (only S. infantis); Ser83Phe - 22,2% (only S. enteritidis); Asp87Asn - 19,4% (S. enteritidis, S. typhimurium, S. hadar, S. newport); Ser83Tyr -11,1% (S. enteritidis and S. infantis) and Asp87Gly - 8,3% (only S. enteritidis). Only in one S. kentucky isolate with high-level fluoroquinolone resistance (MIC of ciprofloxacin > 8,0 mg/l) two substitutions (Ser83Phe and Asp87Asn) were detected. Two Salmonella isolates (S. typhimurium and S. corvallis) had plasmid-mediated quinolone resistance (qnrS). Extended-spectrum cephalosporin resistance was found in 6 Salmonella serovars (1,6%). The bla-genes were detected: of genetic group CTX-M1 - in 10 isolates (serovars S. typhimurium, S. enteritidis, S. abony, S. coeln and S. virchow), CTX-M2 - in 2 S. typhimurium isolates, CTX-M9 - in three S. enteritidis isolates. In one S. typhimurium CTX-M1 and CTX-M2 were detected. The gene of CMY-2 (molecular class C cephalosporinase) was revealed in two isolates (S. newport and S. enteritidis). Our study showed that Salmonella (the main bacterial pathogen of acute diarrhea in children and adults) isolated in Saint-Petersburg had antimicrobial resistance to drugs of choice for salmonellosis treatment. Competing Interests: The authors declare no conflict of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu